{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:25:34Z","timestamp":1760783134416},"reference-count":16,"publisher":"AACN Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,1]]},"abstract":"<jats:p>A 21-year-old man with signs and symptoms of rapidly progressive shock was admitted to the intensive care unit for treatment of suspected sepsis. Levels of inflammatory markers (including procalcitonin) were highly elevated, but no obvious focus of infection was apparent. Initial sepsis therapy included administration of broad-spectrum antibiotics, vasoconstrictors, and drotrecogin alfa. Cultures of blood, sputum, and urine showed no growth, and no viruses were detected. The random (no stimulation with corticotropin) cortisol level at admission was less than 25 nmol\/L. Assays for autoantibodies to the adrenal cortex were strongly positive and confirmed the diagnosis of adrenal failure caused by Addison disease. After initiation of steroid therapy, the patient fully recovered. Although increased procalcitonin levels are considered a reliable and specific indicator of severe generalized infections and bacterial sepsis, elevated procalcitonin levels cannot be relied on when trying to differentiate between addisonian crisis and septic shock.<\/jats:p>","DOI":"10.4037\/ajcc2009805","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T02:05:33Z","timestamp":1237514733000},"page":"96-93","source":"Crossref","is-referenced-by-count":9,"title":["An Unusual Case of Progressive Shock and Highly Elevated Procalcitonin Level"],"prefix":"10.4037","volume":"19","author":[{"given":"Julia","family":"Schumm","sequence":"first","affiliation":[{"name":"Julia Schumm, Ru\u0308diger Pfeifer, Markus Ferrari, Fried-helm Kuethe, and Hans R. Figulla are all physicians in the Department of Internal Medicine I, Friedrich-Schiller-University Jena, Jena, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru\u0308diger","family":"Pfeifer","sequence":"first","affiliation":[{"name":"Julia Schumm, Ru\u0308diger Pfeifer, Markus Ferrari, Fried-helm Kuethe, and Hans R. Figulla are all physicians in the Department of Internal Medicine I, Friedrich-Schiller-University Jena, Jena, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ferrari","sequence":"first","affiliation":[{"name":"Julia Schumm, Ru\u0308diger Pfeifer, Markus Ferrari, Fried-helm Kuethe, and Hans R. Figulla are all physicians in the Department of Internal Medicine I, Friedrich-Schiller-University Jena, Jena, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Kuethe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans R.","family":"Figulla","sequence":"first","affiliation":[{"name":"Julia Schumm, Ru\u0308diger Pfeifer, Markus Ferrari, Fried-helm Kuethe, and Hans R. Figulla are all physicians in the Department of Internal Medicine I, Friedrich-Schiller-University Jena, Jena, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"key":"2020032809153391100_R1","doi-asserted-by":"crossref","unstructured":"Lovas\n            K\n          , Husebye ES. High prevalence and increasing incidence of Addison\u2019s disease in western Norway. Clin Endocrinol (Oxf). 2002;56(6):787\u2013791.","DOI":"10.1046\/j.1365-2265.2002.t01-1-01552.x"},{"key":"2020032809153391100_R2","unstructured":"Reinhart\n            K\n          , Brunkhorst F, Bone H, et al. Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc and the German Interdisciplinary Society for Intensive and Emergency Medicine [in German]. Anaesthesist. 2006; 55(suppl 1):43\u201356."},{"key":"2020032809153391100_R3","doi-asserted-by":"crossref","unstructured":"Brosnan\n            CM\n          , Gowing NF. Addison\u2019s disease. BMJ. 1996; 312(7038):1085\u20131087.","DOI":"10.1136\/bmj.312.7038.1085"},{"key":"2020032809153391100_R4","doi-asserted-by":"crossref","unstructured":"Hatherill\n            M\n          , Jones G, Lim E, Tibby SM, Murdoch IA. Procalcitonin aids diagnosis of adrenocortical failure. Lancet. 1997; 350(9093):1749\u20131750.","DOI":"10.1016\/S0140-6736(05)63573-8"},{"key":"2020032809153391100_R5","doi-asserted-by":"crossref","unstructured":"Kwok\n            MY\n          , Scanlon MC, Slyper AH. Atypical presentation of shock from acute adrenal insufficiency in an adolescent male. Pediatr Emerg Care. 2005;21(6):380\u2013383.","DOI":"10.1097\/01.pec.0000166730.63223.b2"},{"key":"2020032809153391100_R6","doi-asserted-by":"crossref","unstructured":"Assicot\n            M\n          , Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515\u2013518.","DOI":"10.1016\/0140-6736(93)90277-N"},{"key":"2020032809153391100_R7","doi-asserted-by":"crossref","unstructured":"Balc\n            IC\n          , Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003;7(1):85\u201390.","DOI":"10.1186\/cc1843"},{"key":"2020032809153391100_R8","doi-asserted-by":"crossref","unstructured":"Clec\u2019h\n            C\n          , Ferriere F, Karoubi P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med. 2004;32(5):1166\u20131169.","DOI":"10.1097\/01.CCM.0000126263.00551.06"},{"key":"2020032809153391100_R9","doi-asserted-by":"crossref","unstructured":"Harbarth\n            S\n          , Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396\u2013402.","DOI":"10.1164\/ajrccm.164.3.2009052"},{"key":"2020032809153391100_R10","doi-asserted-by":"crossref","unstructured":"Meisner\n            M\n          , Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998; 24(7):680\u2013684.","DOI":"10.1007\/s001340050644"},{"key":"2020032809153391100_R11","doi-asserted-by":"crossref","unstructured":"Mimoz\n            O\n          , Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185\u2013188.","DOI":"10.1007\/s001340050543"},{"key":"2020032809153391100_R12","doi-asserted-by":"crossref","unstructured":"Uzzan\n            B\n          , Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34(7):1996\u20132003.","DOI":"10.1097\/01.CCM.0000226413.54364.36"},{"key":"2020032809153391100_R13","doi-asserted-by":"crossref","unstructured":"Bishayi\n            B\n          , Ghosh S. Immunobiological changes of in vivo glucocorticoid depleted male Swiss albino rats. Immunobiology. 2007;212(1):19\u201327.","DOI":"10.1016\/j.imbio.2006.08.006"},{"key":"2020032809153391100_R14","doi-asserted-by":"crossref","unstructured":"Annane\n            D\n          , Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7): 862\u2013871.","DOI":"10.1001\/jama.288.7.862"},{"key":"2020032809153391100_R15","doi-asserted-by":"crossref","unstructured":"Briegel\n            J\n          , Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27(4):723\u2013732.","DOI":"10.1097\/00003246-199904000-00025"},{"key":"2020032809153391100_R16","doi-asserted-by":"crossref","unstructured":"Cooper\n            MS\n          , Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727\u2013734.","DOI":"10.1056\/NEJMra020529"}],"container-title":["American Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ajcconline\/article-pdf\/19\/1\/96\/96911\/96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ajcconline\/article-pdf\/19\/1\/96\/96911\/96.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T13:15:55Z","timestamp":1585401355000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ajcconline\/article\/19\/1\/96\/5556\/An-Unusual-Case-of-Progressive-Shock-and-Highly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ajcc2009805","relation":{},"ISSN":["1062-3264","1937-710X"],"issn-type":[{"value":"1062-3264","type":"print"},{"value":"1937-710X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,1]]}}}